Oncology 2 - Translational Clinical IRG – OTC
The Oncology 2 – Translational Clinical Integrated Review Group (OTC IRG) will consider applications involving translational and clinical investigations that encompass cancer prevention, diagnosis and treatment.
Dr. Syed Quadri
Chief
IRG Summary
Specifically, the OTC IRG reviews research grant applications related to mechanism of action of cancer therapeutic agents in both in vitro and in vivo model systems; development and evaluation of experimental therapies of neoplastic diseases; translation of basic research to clinical practice; development or optimization of treatment modalities; radiation biology and therapy; chemoprevention; and development of biomarkers/signatures for tumor detection and diagnosis.
Study Sections
- Basic Mechanisms of Cancer Therapeutics Study Section BMCTEnds 10/2018 Council
- Chemo/Dietary Prevention Study Section CDPEnds 10/2018 Council
- Cancer Biomarkers Study Section CBSS
- Cancer Prevention Study Section CPSS
- Mechanisms of Cancer Therapeutics-1
- Mechanisms of Cancer Therapeutics-2 MCT2Starts 01/2020 Council
- Cancer Immunopathology and Immunotherapy Study Section CII
- Clinical Oncology Study Section CONC
- Drug Discovery and Molecular Pharmacology Study Section DMP
- Developmental Therapeutics Study Section DT
- Radiation Therapeutics and Biology Study Section RTB
- Oncology 2 – Translational Clinical Small Business SBIR/STTR Special Emphasis Panels Cancer Drug Development and Therapeutics (CDDT) SBIR/STTR SEP OTC (10)
- Oncology 2 - Translational Clinical Small Business SBIR/STTR Special Emphasis Panels Radiation Therapy and Biology SBIR RTB SBIR SEPOTC (11)
- Oncology 2 - Translational Clinical Small Business SBIR/STTR Special Emphasis Panels Cancer Biotherapeutics Development (CBD) SBIR/STTR SEPOTC (12)
- Oncology 2 – Translational Clinical Small Business SBIR/STTR Special Emphasis Panels Cancer Diagnostics and Treatments (CDT) SBIR/STTR SEPOTC (13)
Applications
- Research project grant (R01, R21, R15, R03, etc), Small Business and Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant applications are reviewed in the OTC IRG.
